BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32456344)

  • 1. Neurological Syndromes Associated with Anti-GAD Antibodies.
    Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
    Tohid H
    Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of stiff person syndrome and other GAD-associated neurological disorders.
    Alexopoulos H; Dalakas MC
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1043-53. PubMed ID: 24168411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
    Madlener M; Strippel C; Thaler FS; Doppler K; Wandinger KP; Lewerenz J; Ringelstein M; Roessling R; Menge T; Wickel J; Kellingshaus C; Mues S; Kraft A; Linsa A; Tauber SC; Berg FT; Gerner ST; Paliantonis A; Finke A; Priller J; Schirotzek I; Süße M; Sühs KW; Urbanek C; Senel M; Sommer C; Kuempfel T; Pruess H; Fink GR; Leypoldt F; Melzer N; Malter MP;
    J Neurol Sci; 2023 Feb; 445():120540. PubMed ID: 36608627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.
    Gresa-Arribas N; Ariño H; Martínez-Hernández E; Petit-Pedrol M; Sabater L; Saiz A; Dalmau J; Graus F
    PLoS One; 2015; 10(3):e0121364. PubMed ID: 25774787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.
    Boronat A; Sabater L; Saiz A; Dalmau J; Graus F
    Neurology; 2011 Mar; 76(9):795-800. PubMed ID: 21357831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
    Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
    Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies to GAD and autoimmune-mediated neurological diseases].
    Mitoma H; Mizusawa H
    Nihon Rinsho; 2013 May; 71(5):921-6. PubMed ID: 23777105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
    Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
    Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
    Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
    Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
    Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
    Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z; Parton M
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.
    Thaler FS; Thaller AL; Biljecki M; Schuh E; Winklmeier S; Mahler CF; Gerhards R; Völk S; Schnorfeil F; Subklewe M; Hohlfeld R; Kümpfel T; Meinl E
    Ann Neurol; 2019 Mar; 85(3):448-454. PubMed ID: 30635933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
    Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
    J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
    Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
    J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.